Advertisement
Screener

Integral Health Asset Management, LLC Historic Quarter Change: Foreign ADRs, New

Integral Health Asset Management, LLC historic quarter change: Foreign ADRs, New

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Integral Health Asset Management, LLC opened 4 positions, added to 4, reduced 0 and sold out of 4.

  • Q3 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q2 2025: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q1 2025: Stock ASCENDIS PHARMA A/S; Country of operation —; Class SPONSORED ADR; Shares before 0.
  • Q4 2024: Stock ASTRAZENECA PLC; Country of operation —; Class SPONSORED ADR; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1773206), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2025ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR060,000+60,000$0$11,928,600+$11,928,6002025-11-14
Q2 2025ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0200,000+200,000$0$13,976,000+$13,976,0002025-08-14
Q1 2025ASCENDIS PHARMA A/S
CUSIP 04351P101
SPONSORED ADR0100,000+100,000$0$15,586,000+$15,586,0002025-05-15
Q4 2024ASTRAZENECA PLC
CUSIP 046353108
SPONSORED ADR0225,000+225,000$0$14,742,000+$14,742,0002025-02-14

Similar Firms

Firm NameCountry13F ValueHoldings
Klingman & Associates, LLCUnited States$2.089B332
CSS LLC/ILUnited States$2.088B961
Analog Century Management LPUnited States$2.094B25
NEW SOUTH CAPITAL MANAGEMENT INCUnited States$2.087B75
Aventail Capital Group, LPUnited States$2.086B170
NLB Skladi, upravljanje premozenja, d.o.o.$2.086B335
Third Point LLCUnited States$2.083B33
Avantyr Capital Partners, LPUnited States$2.082B22
TruWealth Advisors, LLCUnited States$2.081B182
Avala Global LPUnited States$2.081B22